Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 15;21(1):133.
doi: 10.1186/s12882-020-01783-z.

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria

Xiangling Wang  1 , Gauri Bhutani  1 , Lisa E Vaughan  2 , Felicity T Enders  2 , Zejfa Haskic  1 , Dawn Milliner  1 , John C Lieske  3   4 ; investigators of the Rare Kidney Stone Consortium
Collaborators, Affiliations

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria

Xiangling Wang et al. BMC Nephrol. .

Abstract

Background: Patients with primary hyperoxaluria (PH) often develop kidney stones and chronic kidney disease. Noninvasive urine markers reflective of active kidney injury could be useful to gauge the effectiveness of ongoing treatments.

Methods: A panel of biomarkers that reflect different nephron sites and potential mechanisms of injury (clusterin, neutrophil gelatinase-associated lipocalin (NGAL), 8-isoprostane (8IP), monocyte-chemoattractant protein 1(MCP-1), liver-type fatty acid binding protein (L-FABP), heart-type fatty acid binding protein (H-FABP), and osteopontin (OPN)) were measured in 114 urine specimens from 30 PH patients over multiple visits. Generalized estimating equations were used to assess associations between biomarkers and 24 h urine excretions, calculated proximal tubular oxalate concentration (PTOx), and eGFR.

Results: Mean (±SD) age at first visit was 19.5 ± 16.6 years with an estimated glomerular filtration rate (eGFR) of 68.4 ± 21.0 ml/min/1.73m2. After adjustment for age, sex, and eGFR, a higher urine MCP-1 concentration and MCP-1/creatinine ratio was positively associated with CaOx supersaturation (SS). Higher urine NGAL and NGAL/creatinine as well as OPN and OPN/creatinine were associated with higher eGFR. 8IP was negatively associated with PTOx and urinary Ox, but positively associated with CaOx SS.

Conclusion: In PH patients greater urine MCP-1 and 8IP excretion might reflect ongoing collecting tubule crystallization, while greater NGAL and OPN excretion may reflect preservation of kidney mass and function. CaOx crystals, rather than oxalate ion may mediate oxidative stress in hyperoxaluric conditions. Further studies are warranted to determine whether urine MCP-1 excretion predicts long term outcome or is altered in response to treatment.

Keywords: Crystallization; Glomerular filtration rate; Monocyte-chemoattractant protein 1; Primary hyperoxaluria; Renal damage.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest or competing interests. This research is involving human subjects.

Figures

Fig. 1
Fig. 1
Association of CaOx SS with MCP-1. Log-transformed MCP-1 concentration (pg/ml) correlation with CaOx SS (Delta Gibbs units) (R2 = 0.12). Log-transformed MCP-1/Cr ratio (ng/ g creatinine) correlation with CaOx SS (Delta Gibbs units) (R2 = 0.05). In both panels data are shown for the PH cohort only
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. van der Hoeven SM, van Woerden CS, Groothoff JW. Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort. Nephrol Dial Transplant. 2012;27(10):3855–3862. doi: 10.1093/ndt/gfs320. - DOI - PubMed
    1. Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649–658. doi: 10.1056/NEJMra1301564. - DOI - PubMed
    1. Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, Fargue S, Groothoff J, Harambat J, Hoppe B, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729–1736. doi: 10.1093/ndt/gfs078. - DOI - PubMed
    1. Bobbin ML, Rossi JJ. RNA interference (RNAi)-based therapeutics: delivering on the promise? Annu Rev Pharmacol Toxicol. 2016;56:103–122. doi: 10.1146/annurev-pharmtox-010715-103633. - DOI - PubMed
    1. Knauf F, Asplin JR, Granja I, Schmidt IM, Moeckel GW, David RJ, Flavell RA, Aronson PS. NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy. Kidney Int. 2013;84(5):895–901. doi: 10.1038/ki.2013.207. - DOI - PMC - PubMed

Publication types

MeSH terms